Company Profile
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Latest News
Analyst Report: Philip Morris International Inc.
Veeva Systems (VEEV) Could Be 42% Below Fair Value Following Guidance Upgrade
Veeva (VEEV) Stock Trades Below Fair Value Despite 44% Slide
Did Stronger FY27 Guidance and AI Expansion Just Shift Veeva Systems' (VEEV) Investment Narrative?
Is Philip Morris International (PM) Fairly Valued After Its 5 Year Run?
| Sector | Healthcare |
| Industry | Health Information Services |
| Website | https://www.veeva.com |
| Audit Risk | 1 |
| Board Risk | 8 |
| Overall Risk | 10 |
| Market Cap | 30.25B |
| Trailing P/E | 33.02 |
| Forward P/E | 18.56 |
| Trailing Annual Div. Rate | 0 |
| Trailing Annual Div. Yield | 0.00% |
| Trailing EPS | 5.64 |
| Forward EPS | 10.03 |
| Book Value | 44.83 |
| Price-to-Book | 4.15 |
| Enterprise-to-Revenue | 6.94 |
| Enterprise-to-EBITDA | 22.46 |
| Short Ratio | 3.17 |
| Earnings Date | 09/02/2026 |
| Earnings Call Date | 06/03/2026 |
| Earnings Average | 2.22 |
| Earnings Low | 2.2 |
| Earnings High | 2.27 |
| Revenue Average | 905.36M |
| Revenue Low | 902.38M |
| Revenue High | 919.28M |